Mumbai, September 27, 2022 (GPN): Takeda Pharmaceutical Company Limited, a global values-based, R&D-driven biopharmaceutical leader announced that its India operations has become a signatory of the United Nations Global Compact (UNGC), the largest sustainability initiative globally. …
An extended half-life recombinant Factor VIII (rFVIII) treatment for hemophilia A, resulting in lower weekly infusion rates than standard FVIII, providing excellent prophylactic coverage · Adynovate in combination with MYPKFIT®offers personalized treatment and enables HCPs and…
MUMBAI, INDIA, JUNE 25, 2020 (GPN) –Takeda India, part of the Takeda Pharmaceutical Company Limited, a global values-based, R&D-driven biopharmaceutical leader, has announced a donation of ₹ 1.2 Crores to the PM Cares Fund to support India’s fight against…
